The DOI matches its Crossref record; 345 of the 350 references it cites were found in a registry or an index.
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Open accessAbstract
There are several interrelated mechanisms involving iron, dopamine, and neuromelanin in neurons. Neuromelanin accumulates during aging and is the catecholamine-derived pigment of the dopamine neurons of the substantia nigra and norepinephrine neurons of the locus coeruleus, the two neuronal populations most targeted in Parkinson's disease. Many cellular redox reactions rely on iron, however an altered distribution of reactive iron is cytotoxic. In fact, increased levels of iron in the brain of Parkinson's disease patients are present. Dopamine accumulation can induce neuronal death; however, excess dopamine can be removed by converting it into a stable compound like neuromelanin, and this process rescues the cell. Interestingly, the main iron compound in dopamine and norepinephrine neurons is the neuromelanin-iron complex, since neuromelanin is an effective metal chelator. Neuromelanin serves to trap iron and provide neuronal protection from oxidative stress. This equilibrium between iron, dopamine, and neuromelanin is crucial for cell homeostasis and in some cellular circumstances can be disrupted. Indeed, when neuromelanin-containing organelles accumulate high load of toxins and iron during aging a neurodegenerative process can be triggered. In addition, neuromelanin released by degenerating neurons activates microglia and the latter cause neurons death with further release of neuromelanin, then starting a self-propelling mechanism of neuroinflammation and neurodegeneration. Considering the above issues, age-related accumulation of neuromelanin in dopamine neurons shows an interesting link between aging and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, elevated iron in the CNS is associated with ND (reviewed in [133] and [134]), possibly at levels higher than with normal aging [133].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Self-citationHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854
Research works printed but not linked: 1
- Inoue, 1984, Chemical analysis of melanin in Guinea pig inner ear, Ear Res. Japan, 16, 68
Cited by
Sorted by citations
Items 201–300 of 657
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021) · Antioxidants · doi:10.3390/antiox10060824 · Cited by 36
Self-citationLin, Z., Ying, C.-Z., Si, X., Xue, N., Liu, Y., Zheng, R., Chen, Y., Pu, J., & Zhang, B. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01265 · Cited by 41
Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity
Lawana, V., Um, S. Y., Rochet, J., Turesky, R. J., Shannahan, J. H., & Cannon, J. R. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz210 · Cited by 36
Liu, Y., Li, J., He, N., Chen, Y., Jin, Z., Yan, F., & Haacke, E. M. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116935 · Cited by 35
Pamphlett, R., Mak, R., Lee, J., Buckland, M. E., Harding, A. J., Jew, S. K., Paterson, D. J., Jones, M. W., & Lay, P. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233300 · Cited by 36
Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
Malovic, E., Ealy, A., Kanthasamy, A., & Kanthasamy, A. G. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab021 · Cited by 36
Neurotoxicity of metal mixtures
Andrade, V., dos Santos, A. P. M., & Aschner, M. (2021) · Advances in neurotoxicology · doi:10.1016/bs.ant.2020.12.003 · Cited by 36
Henderson, M. X., Henrich, M. T., Geibl, F. F., Oertel, W. H., Brundin, P., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105687 · Cited by 35
Iron Redox Chemistry and Implications in the Parkinson’s Disease Brain
Abeyawardhane, D. L., & Lucas, H. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4609702 · Cited by 35
Xing, Y., Sapuan, A. H., Martín‐Bastida, A., Naidu, S., Tench, C. R., Evans, J., Sare, G. M., Schwarz, S. T., Al–Bachari, S., Parkes, L. M., et al. (2022) · Movement Disorders · doi:10.1002/mds.28934 · Cited by 35
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Bigi, A., Cascella, R., & Cecchi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371345 · Cited by 38
Magnetic resonance imaging as a potential biomarker for Parkinson's disease
Tuite, P. (2015) · Translational research · doi:10.1016/j.trsl.2015.12.006 · Cited by 36
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder
Frosini, D., Cosottini, M., Donatelli, G., Costagli, M., Biagi, L., Pacchetti, C., Terzaghi, M., Cortelli, P., Arnaldi, D., Bonanni, E., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.08.002 · Cited by 35
Mechanistic Effect of Heavy Metals in Neurological Disorder and Brain Cancer
Agnihotri, S. K., & Kesari, K. K. (2019) · Environmental science and engineering · doi:10.1007/978-3-319-96511-6_2 · Cited by 39
Viktorínová, A., & Ďurfinová, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135627 · Cited by 35
CREB Inactivation by HDAC1/PP1γ Contributes to Dopaminergic Neurodegeneration in Parkinson's Disease
Xu, X., He, X., Zhang, Z., Chen, Y., Li, J., Ma, S., Huang, Q., & Li, M. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1419-21.2022 · Cited by 36
Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease
Krainc, T., Monje, M. H. G., Kinsinger, M., Bustos, B. I., & Lubbe, S. J. (2022) · Movement Disorders · doi:10.1002/mds.29260 · Cited by 35
López‐Aguirre, M., Matarazzo, M., Blesa, J., Monje, M. H. G., Rodríguez‐Rojas, R., Sánchez‐Ferro, Á., Obeso, J. A., & Pineda‐Pardo, J. A. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00586-x · Cited by 36
Pesch, B., Casjens, S., Woitalla, D., Dharmadhikari, S., Edmondson, D. A., Zella, M. A. S., Lehnert, M., Lotz, A., Herrmann, L., Muhlack, S., et al. (2019) · Cells · doi:10.3390/cells8020096 · Cited by 33
Arbo, B. D., Schimith, L. E., dos Santos, M. G., & Hort, M. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174800 · Cited by 33
Wakhloo, D., Mahajani, S. U., Oberhauser, J., & Madira, A. E. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.336138 · Cited by 38
Human Colors—The Rainbow Garden of Pathology: What Gives Normal and Pathologic Tissues Their Color?
Piña‐Oviedo, S., Ortíz-Hidalgo, C., & Ayala, A. G. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0274-sa · Cited by 32
Carboni, E., Nicolas, J., Töpperwien, M., Stadelmann, C., Lingor, P., & Salditt, T. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.004331 · Cited by 32
Switching on Endogenous Metal Binding Proteins in Parkinson’s Disease
McLeary, F. A., Rcom-H'cheo-Gauthier, A. N., Goulding, M., Radford, R. A. W., Okita, Y., Faller, P., Chung, R. S., & Pountney, D. L. (2019) · Cells · doi:10.3390/cells8020179 · Cited by 31
Matching ex vivo MRI With Iron Histology: Pearls and Pitfalls
De Barros, A., Arribarat, G., Combis, J., Chaynes, P., & Péran, P. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00068 · Cited by 31
Shi, L., Huang, C., Luo, Q., Rogers, E. A., Xia, Y., Liu, W., Ma, W., Zeng, W., Gong, L., Fang, J., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00215 · Cited by 31
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
Kuter, K. Z., Cenci, M. A., & Carta, A. R. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.004 · Cited by 31
Sian‐Hülsmann, J., & Riederer, P. F. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02192-0 · Cited by 32
Komoto, Y., Ohshiro, T., Yoshida, T., Tarusawa, E., Yagi, T., Washio, T., & Taniguchi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68236-3 · Cited by 31
The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
Sian‐Hülsmann, J., & Riederer, P. F. (2021) · Cells · doi:10.3390/cells10030598 · Cited by 30
Zhang, X., Chai, C., Ghassaban, K., Ye, J., Huang, Y., Zhang, T., Wu, W., Zhu, J., Zhang, X., Haacke, E. M., et al. (2021) · SLEEP · doi:10.1093/sleep/zsab131 · Cited by 32
Iannielli, A., Luoni, M., Giannelli, S. G., Ferese, R., Ordazzo, G., Fossati, M., Raimondi, A., Opazo, F., Corti, O., Prehn, J. H. M., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05330-6 · Cited by 32
Defining a role for hemoglobin in Parkinson’s disease
Freed, J., & Chakrabarti, L. (2016) · npj Parkinson s Disease · doi:10.1038/npjparkd.2016.21 · Cited by 30
A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death
Farzam, A., Chohan, K. L., Strmiskova, M., Hewitt, S. J., Park, D. S., Pezacki, J. P., & Özcelik, D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101377 · Cited by 31
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Chocarro, J., Rico, A. J., Ariznabarreta, G., Roda, E., Honrubia, A., Collantes, M., Peñuelas, I., Vázquez, A., Rodriguez-Perez, A. I., Labandeira-García, J. L., et al. (2023) · Brain · doi:10.1093/brain/awad331 · Cited by 30
NOX1 triggers ferroptosis and ferritinophagy, contributes to Parkinson's disease
Wang, H., Mao, W., Zhang, Y., Feng, W., Bai, B., Ji, B., Chen, J., Cheng, B., & Yan, F. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.007 · Cited by 30
Differential regulation of estrogen in iron metabolism in astrocytes and neurons
Xu, M., Tan, X., Li, N., Wu, H., Wang, Y., Xie, J., & Wang, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27188 · Cited by 31
Caspases orchestrate microglia instrumental functions
Shen, X., Venero, J. L., Joseph, B., & Burguillos, M. Á. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.007 · Cited by 31
Willkommen, D., Lucio, M., Schmitt‐Kopplin, P., Gazzaz, M., Schroeter, M., Sigaroudi, A., & Michalke, B. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.01.005 · Cited by 31
Czarny, P. L., Białek, K. I., Ziółkowska, S., Strycharz, J., & Śliwiński, T. (2019) · Mutagenesis · doi:10.1093/mutage/gez035 · Cited by 32
Parr, A. C., Calabro, F. J., Tervo‐Clemmens, B., Larsen, B., Foran, W., & Luna, B. (2022) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2022.101100 · Cited by 32
Sivakumar, P., Nagashanmugam, K. B., Priyatharshni, S., Lavanya, R., Prabhu, N., & Ponnusamy, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105461 · Cited by 29
Gu, S., Xie, Z.-G., Gu, M., Wang, C., Xu, L., Gao, C., Yuan, X., Wu, Y., Hu, Y., Cao, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62910-6 · Cited by 30
Zeng, M., Qi, L., Guo, Y., Zhu, X., Tang, X., Yong, T., Xie, Y., Wu, Q., Zhang, M., & Chen, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.628860 · Cited by 28
Liu, Y., Xiao, B., Zhang, C., Li, J., Lai, Y., Shi, F., Shen, D. G., Wang, L., Sun, B., Li, Y., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.731109 · Cited by 28
Boag, M. K., Roberts, A., Uversky, V. N., Ma, L., Richardson, D. R., & Pountney, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042378 · Cited by 31
Age-related variability in decision-making: Insights from neurochemistry
Berry, A. S., Jagust, W. J., & Hsu, M. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-00678-9 · Cited by 28
Pain in Parkinson's disease: a neuroanatomy-based approach
Nardelli, D., Gambioli, F., Bartolo, M. I. D., Mancinelli, R., Biagioni, F., Carotti, S., Falato, E., Leodori, G., Puglisi‐Allegra, S., Vivacqua, G., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae210 · Cited by 31
Regional gray matter changes and age predict individual treatment response in Parkinson's disease
Ballarini, T., Mueller, K., Albrecht, F., Růžička, F., Bezdíček, O., Růžička, E., Roth, J., Vymazal, J., Jech, R., & Schroeter, M. L. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.101636 · Cited by 27
Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing
Artyukhova, M. A., Tyurina, Y. Y., Chu, C. T., Zharikova, T. M., Bayır, H., Kagan, V. E., & Timashev, P. S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.007 · Cited by 26
Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation
Tang, S. W., Helmeste, D. M., & Leonard, B. E. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2021.13 · Cited by 27
Bayram, S. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02437-w · Cited by 27
Behl, T., Madaan, P., Sehgal, A., Singh, S., Anwer, M. K., Makeen, H. A., Albratty, M., Mohan, S., & BUNGAU, S. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020678 · Cited by 27
Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214756 · Cited by 27
Self-citationLee, Y., Kang, J. S., Ham, O.-J., Son, M., & Lee, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.925227 · Cited by 27
Ibrahim, K. A., Eleyan, M., El‐Rahman, H. A. A., Khwanes, S. A., & Mohamed, R. A. E. H. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00172-6 · Cited by 29
Towards improved screening of toxins for Parkinson’s risk
Shan, L., Heusinkveld, H. J., Paul, K. C., Hughes, S., Darweesh, S. K. L., Bloem, B. R., & Homberg, J. R. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00615-9 · Cited by 26
Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
Vian, C. D. O., Marinho, M. A. G., Marques, M. D. S., Hort, M. A., Cordeiro, M. F., & Horn, A. P. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14011 · Cited by 28
Leveraging ultra-high field (7T) MRI in psychiatric research
Calabro, F. J., Parr, A. C., Sydnor, V. J., Hetherington, H. P., Prasad, K. M. R., Ibrahim, T. S., Sarpal, D. K., Famalette, A., Verma, P., & Luna, B. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01980-6 · Cited by 29
Bioavailable Trace Metals in Neurological Diseases
Poujois, A., Devedjian, J.-C., Moreau, C., Devos, D., Chaine, P., Woimant, F., & Duce, J. A. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0426-1 · Cited by 26
Kholodar, S. A., Lang, G., Cortopassi, W. A., Iizuka, Y., Brah, H., Jacobson, M. P., & England, P. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00326 · Cited by 26
A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
Prunell, G., & Olivera‐Bravo, S. (2022) · Biomolecules · doi:10.3390/biom12121745 · Cited by 27
Casjens, S., Dydak, U., Dharmadhikari, S., Lotz, A., Lehnert, M., Quetscher, C., Stewig, C., Glaubitz, B., Schmidt‐Wilcke, T., Edmondson, D. A., et al. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.08.004 · Cited by 26
Li, X., Jiang, X., Chu, H.-X., Zhao, Q., Ding, H., & Cai, C.-H. (2020) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2020.12.004 · Cited by 25
Tharani, D., & Sivasubramanian, R. (2023) · Journal of Chemical Sciences · doi:10.1007/s12039-023-02210-0 · Cited by 25
The Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRI
Lee, J., Baek, S., Song, Y., Lim, S., Lee, H., Nguyen, M. P., Kim, E., Huh, G. Y., Chun, S. Y., & Cho, H. (2016) · Scientific Reports · doi:10.1038/srep32647 · Cited by 25
Virel, A., Dudka, I., Laterveer, R., & af Bjerkén, S. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.003 · Cited by 25
Beliveau, V., Nørgaard, M., Birkl, C. R., Seppi, K., & Scherfler, C. (2021) · Human Brain Mapping · doi:10.1002/hbm.25604 · Cited by 25
Parr, A. C., Perica, M. I., Calabro, F. J., Foran, W., Moon, C., Hetherington, H. P., & Luna, B. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02860-7 · Cited by 23
Iron Overload Impairs Autophagy: Effects of Rapamycin in Ameliorating Iron-Related Memory Deficits
Uberti, V. H., de Freitas, B. S., Molz, P., Bromberg, E., & Schröder, N. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01794-4 · Cited by 25
dos Santos, M. F., Roxo, C., & Solá, S. (2021) · Antioxidants · doi:10.3390/antiox10071088 · Cited by 25
Subcortical brain iron deposition in individuals with schizophrenia
Sonnenschein, S. F., Parr, A. C., Larsen, B., Calabro, F. J., Foran, W., Eack, S. M., Luna, B., & Sarpal, D. K. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.013 · Cited by 24
Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation
Ortiz de Ora, L., Balsamo, J. M., Uyeda, K. S., & Bess, E. N. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00095 · Cited by 24
Xu, H., Jiang, H. F., & Xie, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00071 · Cited by 25
Alcalde, L. A., de Freitas, B. S., Machado, G. D. B., Crivelaro, P. C. D. F., Dornelles, V. C., Gus, H., Monteiro, R. T., Kist, L. W., Bogo, M. R., & Schröder, N. (2018) · BioMetals · doi:10.1007/s10534-018-0135-1 · Cited by 25
Iron-induced cytotoxicity mediated by endolysosomal TRPML1 channels is reverted by TFEB
Fernández, B., Olmedo, P., Gil, F., Fdez, E., Naaldijk, Y., Rivero-Ríos, P., Bracher, F., Grimm, C. M., Churchill, G. C., & Hilfiker, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05504-2 · Cited by 23
Integrated gender-related effects of profenofos and paclobutrazol on neurotransmitters in mouse
Xu, M., & Yang, F. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.110085 · Cited by 23
Bashat, D. B., Thaler, A., Lerman, H., Even‐Sapir, E., Hutchison, M., Evans, K. C., Orr‐Urtreger, A., Cedarbaum, J. M., Droby, A., Giladi, N., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00405-9 · Cited by 23
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
Cai, W., Wakamatsu, K., Zucca, F. A., Wang, Q., Yang, K., Honarvar, N. M., Srivastava, P., Tanaka, H., Holly, G., Casella, L., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102414 · Cited by 24
Self-citationAriz, M., Martı́nez, M., Álvarez, I., Fernández‐Seara, M. A., Castellanos, G., Pástor, P., Pastor, M. A., & Ortíz-de-Solórzano, C. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29073 · Cited by 23
Morphology-tunable polydopamine nanoparticles and their application in Fe 3+ detection
Qi, P., Zhang, D., & Wan, Y. (2017) · Talanta · doi:10.1016/j.talanta.2017.03.093 · Cited by 23
Brooks, J., Everett, J. L., Lermyte, F., Tjhin, V. T., Sadler, P. J., Telling, N. D., & Collingwood, J. F. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126555 · Cited by 23
Nigrostriatal iron accumulation in the progression of Parkinson’s disease
López‐Aguirre, M., Balzano, T., Monje, M. H. G., Esteban-García, N., Martínez‐Fernández, R., del Rey, N. L., Ciorraga, M., Sánchez‐Ferro, Á., Trigo‐Damas, I., Blesa, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00911-6 · Cited by 22
Cassera, E., Ferrari, E., Vignati, D. A. L., & Capucciati, A. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111366 · Cited by 24
Self-citationThe role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
Burbulla, L. F., & Krainc, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104545 · Cited by 23
Blazer, A., Chengappa, K. N. R., Foran, W., Parr, A. C., Kahn, C. E., Luna, B., & Sarpal, D. K. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06138-0 · Cited by 24
DNA versus RNA oxidation in Parkinson’s disease: Which is more important?
Gmitterová, K., Gawinecka, J., Heinemann, U., Valkovič, P., & Zerr, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.048 · Cited by 22
Wakamatsu, K., Nakao, K., Tanaka, H., Kitahori, Y., Tanaka, Y., Ojika, M., & Ito, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102575 · Cited by 22
Yin, M., Li, S., Wan, Y., Feng, L., Zhao, X., Zhang, S., Liu, S., Cao, P., & Wang, H. (2019) · Chemical Communications · doi:10.1039/c9cc06211d · Cited by 22
Bacchella, C., Nicolis, S., Dell’Acqua, S., Rizzarelli, E., Monzani, E., & Casella, L. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b03153 · Cited by 23
Self-citationKrupička, R., Mareček, S., Malá, C., Lang, M., Klempíř, O., Duspivová, T., Široká, R., Jarošíková, T., Keller, J., Šonka, K., et al. (2019) · Physiological Research · doi:10.33549/physiolres.934380 · Cited by 22
Label‐Free Nanoimaging of Neuromelanin in the Brain by Soft X‐ray Spectromicroscopy
Brooks, J., Everett, J. L., Lermyte, F., Tjhin, V. T., Banerjee, S., O’Connor, P. B., Morris, C. M., Sadler, P. J., Telling, N. D., & Collingwood, J. F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202000239 · Cited by 21
Huenchuguala, S., & Segura‐Aguilar, J. (2024) · Antioxidants · doi:10.3390/antiox13091125 · Cited by 23
Self-citationImaging Parkinsonian Pathology in Substantia Nigra with MRI
Huddleston, D. E., Langley, J. A., Dušek, P., He, N., Faraco, C. C., Crosson, B., Factor, S. A., & Hu, X. P. (2018) · Current Radiology Reports · doi:10.1007/s40134-018-0272-x · Cited by 21
Chen, Y., Li, Y., Wang, S., Zhou, T.-T., Chen, N., & Yuan, Y. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03564-6 · Cited by 22
Wulf, M., Barkovits, K., Schork, K., Eisenacher, M., Riederer, P. F., Gerlach, M., Eggers, B., & Marcus, K. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02530-4 · Cited by 22
Chintaluri, C., & Vogels, T. P. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306525120 · Cited by 24
The delta‐opioid receptor and Parkinson’s disease
Huang, J., Ren, Y., Xu, Y., Chen, T., Xia, T. C., Li, Z., Zhao, J., Hua, F., Sheng, S., & Xia, Y. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13045 · Cited by 21
Jin, L., Wan, W., Wang, L., Wang, C., Xiao, J., Zhang, F., Zhao, J., Wang, J., Zhan, C., & Zhong, C. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.034 · Cited by 21
Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes
Arribarat, G., & Péran, P. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000796 · Cited by 21
Metadata
- Authors
- Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Chile (CL)
- Universidad Santo Tomás (CL)
- Columbia University Irving Medical Center (US)
- Jagiellonian University (PL)
- University of Pavia (IT)
- Corresponding author
- Zecca, Luigi
- ORCID
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 155
- Pages
- 96-119
- ISSN
- 0301-0082 (ISSN-L)
- PMC
- PMC4826627
- OpenAlex
- W1913653254
- Cited by
- 659
- References
- 350
- Citations by year
- 2026: 43 · 2025: 59 · 2024: 58 · 2023: 73 · 2022: 74 · 2021: 72 · 2020: 70 · 2019: 77 · 2018: 53 · 2017: 46
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute on Drug Abuse (P01DA010154, R01DA007418)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- neuromelanin, iron, dopamine, brain aging, Parkinson's disease, substantia nigra, locus coeruleus, noradrenergic neurons, oxidative stress, metal chelation, neuroinflammation, microglial activation, neurodegeneration, redox homeostasis
- MeSH terms
- Aging, Animals, Dopamine, Humans, Iron, Melanins, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
